A comparative analysis of novel cardiac biomarkers (sST2, GDF-15, Galectin-3, suPAR, H-FABP and Fetuin-A) in patients with heart failure, STEMI and controls without cardiovascular disease

26 May 2018 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Assistant Professor Peter Jirak

Salzburg university hospital, Salzburg (Austria)

27 More presentations in this session

Presentation thumbnail

What is the best imaging technique to explore right ventricular function at the time of multimodality cardiovascular imaging?

Doctor S. Cazalbou (Toulouse, FR)

Abstract Slides

Presentation thumbnail

The assessment of myocardial deformation in patients with acute decompensation of ischemic heart failure with reduced ejection fraction by 2d-speckle tracking technology

Miss E. Kruchinkina (Tomsk, RU)

Presentation thumbnail

Low Levels of CA125 and Risk of Short-term Events after an Episode of Acute Heart Failure

Presentation thumbnail

Incremental value of intact fibroblast Growth factor 23 to natriuretic peptides for long-term risk estimation of heart failure patientsg

Professor D. Gruson (Brussels, BE)

Abstract Slides

Presentation thumbnail

N-terminal pro-B type natriuretic peptide imply left ventricular diastolic function but is a low sensitivity marker

Professor W. Chung (Incheon, KR)

Access the full session

Session thumbnail

Poster Session 1 - Chronic Heart Failure – Diagnostic Methods

The Event

Heart Failure 2018

26 May - 29 May 2018

You may be interested in

Congress Presentation

The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure

Congress Session

From genetic signatures to clinical implications

Congress Presentation

Novel biomarkers reveal distinct biological phenotypes in heart failure with preserved vs reduced ejection fraction

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources